Crispr Gene-Editing Drugs Show Promise in Preliminary Study

Sept. 16, 2022 7:18 am ET Intellia Therapeutics Inc. reported encouraging early-stage study results for its…

Pfizer Agrees to $5.4 Billion Deal for Global Blood Therapeutics

Updated Aug. 8, 2022 7:11 am ET Pfizer Inc. has agreed to buy Global Blood Therapeutics…

WSJ News Exclusive | Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion

Pfizer is in advanced talks to buy Global Blood Therapeutics the maker of a recently approved…